Skip to main content

Advertisement

SpringerLink
Log in

Serum copper and ferroportin in monocytes of hemodialysis patients are both decreased but unassociated

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Disturbed iron homeostasis contributes to resistance to recombinant human erythropoietin (rHuEpo) in hemodialysis (HD) patients. Although increased hepcidin, which downregulates the iron exporter ferroportin, had been incriminated, such an association has not been confirmed. Albeit not universally accepted, it has been supported that in case of copper deficiency, decreased activity of multicopper oxidases induces endocytosis and degradation of ferroportin. Ferroportin in monocytes, serum copper, ceruloplasmin and markers of iron status were measured, and associations with rHuEpo resistance index (ERI) were evaluated.

Methods

After a 4-week washout period from iron treatment, 34 HD patients and 20 healthy volunteers enrolled in the study. Ferroportin was assessed by means of Western blotting, copper colorimetrically, whereas ceruloplasmin with enzyme-linked immunosorbent assay. Hemoglobin, serum iron, ferritin and transferrin saturation (TSAT) were also measured.

Results

Ferroportin in monocytes of HD patients was decreased. Serum copper, ceruloplasmin, iron and TSAT were decreased. No correlation between copper or ceruloplasmin and ferroportin was detected. ERI was negatively correlated with ferroportin and all the markers of iron adequacy, but not with copper or ceruloplasmin.

Conclusion

Although copper deficiency and decreased ferroportin are common in HD patients, copper might not play role in ferroportin level in monocytes and in iron metabolism in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Eleftheriadis T, Liakopoulos V, Antoniadi G, Kartsios C, Stefanidis I (2009) The role of hepcidin in iron homeostasis and anemia in hemodialysis patients. Semin Dial 22(1):70–77. doi:10.1111/j.1525-139X.2008.00532.x

    Article  PubMed  Google Scholar 

  2. Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A (2010) Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management. Blood Purif 29(1):1–12. doi:10.1159/000245041

    Article  PubMed  Google Scholar 

  3. Eleftheriadis T, Kartsios C, Liakopoulos V, Antoniadi G, Ditsa M, Papadopoulos C, Anifandis G, Skirta A, Markala D, Stefanidis I (2006) Does hepcidin affect erythropoiesis in hemodialysis patients? Acta Haematol 116(4):238–244. doi:10.1159/000095873

    Article  CAS  PubMed  Google Scholar 

  4. Ford BA, Eby CS, Scott MG, Coyne DW (2010) Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients. Kidney Int 78(8):769–773. doi:10.1038/ki.2010.254

    Article  CAS  PubMed  Google Scholar 

  5. Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A (2010) Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transpl 25(12):3996–4002. doi:10.1093/ndt/gfq321

    Article  CAS  Google Scholar 

  6. van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, Nube MJ, Penne EL, Gaillard CA, Wetzels JF, Wiegerinck ET, Swinkels DW, Blankestijn PJ, Ter Wee PM (2012) Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS One 7(7):e39783. doi:10.1371/journal.pone.0039783

    Article  PubMed Central  PubMed  Google Scholar 

  7. Eleftheriadis T, Pissas G, Remoundou M, Filippidis G, Antoniadi G, Oustampasidou N, Liakopoulos V, Stefanidis I (2014) Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin. Int Urol Nephrol 46(1):161–167. doi:10.1007/s11255-013-0497-9

    Article  CAS  PubMed  Google Scholar 

  8. Ward DM, Kaplan J (2012) Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta 1823(9):1426–1433. doi:10.1016/j.bbamcr.2012.03.004

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. McDermott JA, Huber CT, Osaki S, Frieden E (1968) Role of iron in the oxidase activity of ceruloplasmin. Biochim Biophys Acta 151(3):541–557

    Article  CAS  PubMed  Google Scholar 

  10. Osaki S, Johnson DA, Frieden E (1971) The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J Biol Chem 246(9):3018–3023

    CAS  PubMed  Google Scholar 

  11. Collins JF, Klevay LM (2011) Copper. Adv Nutr 2(6):520–522. doi:10.3945/an.111.001222

    Article  PubMed Central  PubMed  Google Scholar 

  12. Sarkar J, Seshadri V, Tripoulas NA, Ketterer ME, Fox PL (2003) Role of ceruloplasmin in macrophage iron efflux during hypoxia. J Biol Chem 278(45):44018–44024. doi:10.1074/jbc.M304926200

    Article  CAS  PubMed  Google Scholar 

  13. De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J (2007) Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26(12):2823–2831. doi:10.1038/sj.emboj.7601735

    Article  PubMed Central  PubMed  Google Scholar 

  14. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, Anderson GJ (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21(2):195–199. doi:10.1038/5979

    Article  CAS  PubMed  Google Scholar 

  15. di Patti MC, Maio N, Rizzo G, De Francesco G, Persichini T, Colasanti M, Polticelli F, Musci G (2009) Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia. J Biol Chem 284(7):4545–4554. doi:10.1074/jbc.M805688200

    Article  PubMed  Google Scholar 

  16. Prohaska JR, Broderius M (2012) Copper deficiency has minimal impact on ferroportin expression or function. Biometals 25(4):633–642. doi:10.1007/s10534-012-9521-2

    Article  CAS  PubMed  Google Scholar 

  17. Erceg-Hurn DM, Mirosevich VM (2008) Modern robust statistical methods: an easy way to maximize the accuracy and power of your research. Am Psychol 63(7):591–601. doi:10.1037/0003-066X.63.7.591

    Article  PubMed  Google Scholar 

  18. Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341(26):1986–1995. doi:10.1056/NEJM199912233412607

    Article  CAS  PubMed  Google Scholar 

  19. Lin TH, Chen JG, Liaw JM, Juang JG (1996) Trace elements and lipid peroxidation in uremic patients on hemodialysis. Biol Trace Elem Res 51(3):277–283. doi:10.1007/BF02784082

    Article  CAS  PubMed  Google Scholar 

  20. Navarro-Alarcon M, Reyes-Perez A, Lopez-Garcia H, Palomares-Bayo M, Olalla-Herrera M, Lopez-Martinez MC (2006) Longitudinal study of serum zinc and copper levels in hemodialysis patients and their relation to biochemical markers. Biol Trace Elem Res 113(3):209–222. doi:10.1385/BTER:113:3:209

    Article  CAS  PubMed  Google Scholar 

  21. Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF (2006) Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res 109(2):115–121. doi:10.1385/BTER:109:2:115

    Article  CAS  PubMed  Google Scholar 

  22. Ongajooth L, Ongajyooth S, Likidlilid A, Chantachum Y, Shayakul C, Nilwarangkur S (1996) Role of lipid peroxidation, trace elements and anti-oxidant enzymes in chronic renal disease patients. J Med Assoc Thai 79(12):791–800

    CAS  PubMed  Google Scholar 

  23. Emenaker NJ, DiSilvestro RA, Nahman NS Jr, Percival S (1996) Copper-related blood indexes in kidney dialysis patients. Am J Clin Nutr 64(5):757–760

    CAS  PubMed  Google Scholar 

  24. Weissgarten J, Berman S, Bilchinsky R, Modai D, Averbukh Z (2001) Total cell-associated Zn2+ and Cu2+ and proliferative responsiveness of peripheral blood mononuclear cells from patients on chronic hemodialysis. Metabolism 50(3):270–276

    Article  CAS  PubMed  Google Scholar 

  25. Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR (2009) Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis 16(2):143–151. doi:10.1053/j.ackd.2008.12.008

    Article  PubMed  Google Scholar 

  26. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20(5):440–451. doi:10.1111/j.1525-139X.2007.00283.x

    Article  PubMed  Google Scholar 

  27. Torti FM, Torti SV (2002) Regulation of ferritin genes and protein. Blood 99(10):3505–3516

    Article  CAS  PubMed  Google Scholar 

  28. Collins JF, Prohaska JR, Knutson MD (2010) Metabolic crossroads of iron and copper. Nutr Rev 68(3):133–147. doi:10.1111/j.1753-4887.2010.00271.x

    Article  PubMed Central  PubMed  Google Scholar 

  29. Higuchi T, Matsukawa Y, Okada K, Oikawa O, Yamazaki T, Ohnishi Y, Fujita T, Fukuda N, Soma M, Matsumoto K (2006) Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia. Intern Med 45(5):271–273

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Nephrology, Medical School, University of Thessaly, Neo Ktirio, Mezourlo Hill, 411 10, Larissa, Greece

    Theodoros Eleftheriadis, Georgios Pissas, Georgia Antoniadi, Georgios Filippidis, Spyridon Golfinopoulos, Aginor Spanoulis, Vassilios Liakopoulos & Ioannis Stefanidis

Authors
  1. Theodoros Eleftheriadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georgios Pissas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Georgia Antoniadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georgios Filippidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Spyridon Golfinopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aginor Spanoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vassilios Liakopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ioannis Stefanidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodoros Eleftheriadis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eleftheriadis, T., Pissas, G., Antoniadi, G. et al. Serum copper and ferroportin in monocytes of hemodialysis patients are both decreased but unassociated. Int Urol Nephrol 46, 1825–1831 (2014). https://doi.org/10.1007/s11255-014-0725-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0725-y

Keywords

Search

Navigation